Redirect to:

This page is a redirect. The following categories are used to track and monitor this redirect:

From an avoided double redirect: This is a redirect from an alternative title or related topic of Cure–north merger, another redirect to the same title. Because double redirects are disallowed, both pages currently point to English-language vowel changes before historic /r/ (but with different anchors).
- If Cure–north merger is retargeted or is expanded into a separate article, template, or other project page, this redirect will be recategorized to be updated.

To a section: This is a redirect from a topic that does not have its own page to a section of a page on the subject. For redirects to embedded anchors on a page, use {{R to anchor}} instead.

From a subtopic: This is a redirect from a subtopic of the target article or section.
- If the redirected subtopic could potentially have its own article in the future, then also tag the redirect with {{R with possibilities}} and {{R printworthy}}.

When appropriate, protection levels are automatically sensed, described and categorized.

Cure–force merger